FDMT vs REG · rev $37.0K vs P/E 34, $12.93B cap
4D Molecular Therapeutics Inc (FDMT) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
REG does not have a complete income-statement cache yet.
FDMT currently screens at market cap $518.1M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the FDMT and REG stock pages for the full models.
Not investment advice.